The Nomination Committee proposes unchanged Board fees

Report this content

As a consequence of the situation concerning the coronavirus pandemic, Essity’s Nomination Committee has decided to withdraw its proposal that Essity’s Annual General Meeting on April 2, 2020 approve an increase in Board fees (item 11 on the agenda). 

Instead, the Nomination Committee proposes unchanged Board fees compared with 2019. The Nomination Committee’s all other proposals to the Annual General Meeting remain unchanged.

For further information, please contact:
Helena Stjernholm, Chairman of Nomination Committee, +46 8 666 64 00    
Per Lorentz, Vice President Corporate Communications, +46 8 788 52 51,
Johan Karlsson, Vice President Investor Relations, +46 8 788 51 30,

Essity is a leading global hygiene and health company. We are dedicated to improving well-being through our products and services. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands, such as JOBST, Leukoplast, Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. Essity has about 46,000 employees. Net sales in 2019 amounted to approximately SEK 129bn (EUR 12.2bn). The company’s headquarters is located in Stockholm, Sweden, and Essity is listed on Nasdaq Stockholm. Essity breaks barriers to well-being and contributes to a healthy, sustainable and circular society. More information at